Cargando…

Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report

BACKGROUND: The prognosis of stage IV gastric cancer and human epidermal growth factor 2 (HER2)-positive gastric cancer is poor, although new drugs and regimens have been developed. We report a case of a patient with stage IV HER2-positive gastric cancer treated successfully by conversion therapy an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakaguchi, Masazumi, Shimoike, Norihiro, Akagawa, Shin, Kanaya, Seiichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385396/ https://www.ncbi.nlm.nih.gov/pubmed/30791934 http://dx.doi.org/10.1186/s13256-019-2001-3

Ejemplares similares

Laparoscopic gastrectomy with and without prophylactic drains in gastric cancer: a propensity score-matched analysis
por: Shimoike, Norihiro, et al.
Publicado: (2019)

Current treatment strategies for patients with only peritoneal cytology positive stage IV gastric cancer
por: Bausys, Augustinas, et al.
Publicado: (2021)

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
por: Matsumura, Sosuke, et al.
Publicado: (2023)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Is D2 laparoscopic gastrectomy essential for elderly patients with advanced gastric cancer?—reply letter
por: Sakaguchi, Masazumi
Publicado: (2022)

Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer
por: Cho, Jang Ho, et al.
Publicado: (2017)

Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer?
por: Lee, Chang Min, et al.
Publicado: (2017)

Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer
por: Hino, Kaori, et al.
Publicado: (2022)

Epidermal growth factor and prostaglandin E2 levels in Helicobacter pylori-positive gastric intraepithelial neoplasia
por: Chen, Zhitao, et al.
Publicado: (2016)

Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy
por: Kadowaki, Shigenori, et al.
Publicado: (2014)

Epidermal growth factor receptor structural alterations in gastric cancer
por: Moutinho, Cátia, et al.
Publicado: (2008)

Recent advances and optimal management of human epidermal growth factor receptor-2-positive early-stage breast cancer
por: Batoo, Sameer, et al.
Publicado: (2019)

The expression of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2 based on tumor location affect survival in gastric cancer
por: Li, Guo-Cai, et al.
Publicado: (2020)

The Use of Epidermal Growth Factor Receptor Type 2-Targeting Tyrosine Kinase Inhibitors in the Management of Epidermal Growth Factor Receptor Type 2-Positive Gastric Cancer: A Narrative Review
por: AlMazmomy, Asim M, et al.
Publicado: (2019)

The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
por: Uprety, Dipesh, et al.
Publicado: (2018)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Intracorporeal Anastomosis in Laparoscopic Gastric Cancer Surgery
por: Hosogi, Hisahiro, et al.
Publicado: (2012)

Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells
por: Akagi, M, et al.
Publicado: (2003)

Functional epidermal growth factor gene polymorphisms and risk of gastric cancer
por: ZHAN, ZHEN, et al.
Publicado: (2013)

Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer
por: Arienti, Chiara, et al.
Publicado: (2019)

Detection and Significance of Human Epidermal Growth Factor Receptor 2 Expression in Gastric Adenocarcinoma
por: Halder, Sutapa, et al.
Publicado: (2017)

Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population
por: Shabbir, Asma, et al.
Publicado: (2018)

Human epidermal growth factor 2 overexpressed alpha-fetoprotein-producing-gastric cancer
por: Shimizu, Hiroko, et al.
Publicado: (2023)

Expression of Epidermal Growth Factor, Transforming Growth Factor‐α and Their Receptor Genes in Human Gastric Carcinomas; Implication for Autocrine Growth
por: Yoshida, Kazuhiro, et al.
Publicado: (1990)

Effects of vascular endothelial growth factor and epidermal growth factor on biological properties of gastric cancer cells
por: Li, Chunfeng, et al.
Publicado: (2019)

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer
por: Atmaca, Akin, et al.
Publicado: (2012)

Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer
por: Weng, Xiaoling, et al.
Publicado: (2015)

Tumor microenvironment characterization in stage IV gastric cancer
por: Yang, Feng, et al.
Publicado: (2021)

Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy
por: Amanda, Gina, et al.
Publicado: (2017)

Expression of Amphiregulin, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastric Carcinomas
por: Kitadai, Yasuhiko, et al.
Publicado: (1993)

The Combination of Seven Preoperative Markers for Predicting Patients with Gastric Cancer to Be Either Stage IV or Non-Stage IV
por: Ge, Wei, et al.
Publicado: (2018)

Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Locoregional therapy with α‐emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2‐positive gastric cancer in mice
por: Li, Huizi Keiko, et al.
Publicado: (2017)

Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism
por: Yan, Yidan, et al.
Publicado: (2020)

Gastrectomy for stage IV gastric cancer: a comparison of different treatment strategies from the SEER database
por: Desiderio, Jacopo, et al.
Publicado: (2021)

Enhancement of epidermal regeneration by biosynthetic epidermal growth factor
Publicado: (1986)

Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review
por: Ran, Ran, et al.
Publicado: (2022)

Stage IV gastric cancer successfully treated by multidisciplinary therapy including chemotherapy, immunotherapy, and surgery: a case report
por: Kawamoto, Makoto, et al.
Publicado: (2017)

The use of epidermal growth factor in dermatological practice
por: Shin, Sun Hye, et al.
Publicado: (2022)

Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Cancer
por: Seo, Kyung Won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tniftf9bccg93l5bbfbk5njcbc